India, Aug. 25 -- This appointment reflects the Board's confidence in Dr. Kondru's ability to drive innovation and operational excellence and underscores its commitment to advancing clinical research through scientific excellence, technology, and artificial intelligence.

Dr. Kondru joined the Emmes Group in 2024 and most recently served as CEO of Veridix, the company's AI, technology, and data sciences business. He assumes the role at a pivotal moment for Emmes: a company built on almost 50 years of scientific rigor now positioned to combine that legacy with modern AI and technology to accelerate the pace of biomedical discovery. Dr. Kondru has demonstrated exceptional leadership in technology-driven innovation across The Emmes Group and...